ABVC BIOPHARMA, INC.
ABVC BIOPHARMA, INC.
Insider Sentiment (TTM):
Last Purchase:2010-05-11Last Sale:2009-01-23Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:816,526Shares Outstanding:25,448,516Institutional Ownership Pct.:3.21%
Earnings Market Reaction:
Filing Date:2026-05-18Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | 0 | 1 | 2 | - | 1 | 1 | 0 | -0 | 0 | 0 | 1 | - | |||||
Third Parties | 1 | - | - | - | - | - | - | - | - | - | - | - | |||||
Assets | |||||||||||||||||
Cash | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Assets Current | |||||||||||||||||
Restricted Cash And Cash Equivalents At Carrying V… | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Cash And Cash Equivalents At Carrying Value | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Restricted Cash | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | |||||
Restricted Cash Current | - | 1 | 20 | 20 | 1 | 1 | 1 | 1 | - | 20 | - | - | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | - | - | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Other Receivables Net Current | - | - | - | 1 | - | - | - | - | - | - | - | - | |||||
Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 1 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Property Plant And Equipment Net | 13 | 13 | 13 | 8 | 8 | 1 | 1 | 8 | 8 | 1 | 8 | 1 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Investments | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 1 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Prepaid Expense Noncurrent | 2 | 1 | 1 | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Security Deposit | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | |||||
Assets | 20 | 21 | 21 | 16 | 15 | 8 | 8 | 8 | 8 | 8 | 17 | 9 | |||||
Short Term Bank Loans And Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Liabilities | |||||||||||||||||
Liabilities And Stockhold… | |||||||||||||||||
Other Receivable After Allowance For Credit Loss N… | - | - | - | - | - | 4 | - | - | 0 | 0 | - | - | |||||
Liabilities Current | |||||||||||||||||
Short Term Borrowings | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | - | - | |||||
Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | 4 | 4 | 3 | |||||
Customer Advances Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Current | - | - | - | 1 | - | - | 0 | 0 | - | 0 | - | - | |||||
Convertible Notes Payable Current | - | - | - | 0 | - | - | - | 1 | 1 | 1 | - | - | |||||
Taxes Payable Current | 0 | 0 | 0 | 0 | - | - | - | - | 0 | 0 | - | - | |||||
Liabilities Current | 5 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 5 | 6 | |||||
Security Deposit Liability | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 2 | 3 | |||||
Liabilities | 7 | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | 10 | |||||
Equity | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 97 | 96 | 94 | 86 | 84 | 79 | 78 | 87 | 86 | 74 | 81 | 68 | |||||
Stockholders Equity Note Subscriptions Receivable | - | - | - | - | - | - | - | - | -0 | -0 | -1 | -1 | |||||
Retained Earnings Accumulated Deficit | -78 | -77 | -74 | -72 | -70 | -69 | -71 | -70 | -69 | -64 | -62 | -59 | |||||
Accumulated Other Comprehensive Income Loss Define… | - | - | - | - | - | - | - | - | - | - | 1 | 1 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - | |||||
Treasury Stock Value | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | |||||
Stockholders Equity | 11 | 13 | 12 | 9 | 5 | 1 | 2 | 2 | 1 | 1 | 9 | -0 | |||||
Minority Interest | 2 | 2 | 2 | 2 | 3 | -1 | -0 | -0 | -0 | -0 | -0 | 0 | |||||
Liabilities And Stockholders Equity | 20 | 21 | 21 | 16 | 15 | 8 | 8 | 8 | 8 | 8 | 17 | 9 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | |||||
Common Stock Shares Issued | 387 | 376 | 363 | 391 | 384 | 347 | 318 | 301 | 282 | 278 | 289 | 298 | |||||
Shares Outstanding | 26 | 25 | 24 | 20 | 15 | 14 | 13 | 12 | 11 | 4 | 5 | 3 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.21% | 41.12% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 8.49% | 73.58% | 216.04% | -10.77% | 1.01% | -5.72% | -8.45% | -17.91% | -30.41% | -29.58% | -24.65% | -19.72% |
| 2024 | -27.38% | -30.84% | -32.71% | -12.13% | -17.33% | -12.00% | -8.35% | 19.06% | -6.17% | 35.20% | 72.07% | 247.49% |
| 2023 | - | - | - | -41.18% | -56.68% | -37.43% | -4.80% | 9.60% | 20.00% | 3.25% | -12.20% | -35.45% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.12 | 0.41 | 0.51 | 0.42 | 0.22 | 0.33 | 0.35 | 0.37 | 0.29 | 0.27 | 0.46 | 0.37 | |||||
| Quick Ratio | 0.07 | 0.35 | 0.44 | 0.39 | 0.20 | 0.32 | 0.33 | 0.33 | 0.23 | 0.25 | 0.44 | 0.34 | |||||
| Working Capital | -4.74M | -3.66M | -3.23M | -3.76M | -5.26M | -4.38M | -4.08M | -3.94M | -4.38M | -4.45M | -2.87M | -3.64M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.64 | 0.58 | 0.56 | 0.71 | 1.28 | 9.41 | 3.92 | 4.22 | 4.47 | 5.21 | 0.83 | -25.54 | |||||
| Interest Coverage TTM | -33.14 | -17.20 | -9.43 | -5.06 | -2.95 | -3.54 | -2.04 | -1.98 | -2.47 | -2.71 | -6.16 | -25.32 | |||||
| Debt Ratio | 0.35 | 0.37 | 0.32 | 0.42 | 0.47 | 0.90 | 0.83 | 0.81 | 0.82 | 0.84 | 0.45 | 1.04 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.06 | 0.04 | 0.05 | 0.07 | 0.03 | 0.00 | -0.01 | 0.02 | 0.08 | 0.09 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | 1.40 | 99.93 | -267.70 | 119.55 | 8.59 | 51.37 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | 260.71 | 3.65 | -1.36 | 3.05 | 42.51 | 7.11 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.34 | -0.39 | -0.27 | -0.26 | -0.21 | -0.45 | -0.41 | -0.71 | -0.96 | -1.91 | -2.98 | -3.80 | |||||
| Free Cash Flow Per Share TTM | -0.13 | -0.15 | -0.13 | -0.12 | -0.09 | -0.15 | -0.12 | -0.26 | -0.38 | -0.97 | -1.05 | -1.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | 99.85% | 8.58% | -1,452.88% | 723.04% | -98.15% | 29.83% | 33.31% | |||||
| Operating Profit Margin TTM | -25,270.54% | -22,503.10% | -618.20% | -785.80% | -409.25% | -923.34% | -1,131.65% | -25,095.89% | 8,986.58% | -4,439.24% | -897.50% | -1,020.97% | |||||
| Net Profit Margin TTM | -27,554.10% | -24,886.10% | -683.31% | -897.74% | -507.32% | -1,032.02% | -1,289.24% | -31,792.93% | 10,954.61% | -5,432.56% | -1,157.24% | -1,171.57% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -94.92% | -93.76% | 129.48% | 1,904.43% | -830.16% | 234.31% | -61.88% | -97.63% | -106.21% | -84.28% | 1,598.70% | 806.45% | |||||
| Net Income Growth (1Y) | 175.93% | 50.38% | 21.63% | -43.40% | -66.19% | -36.49% | -57.53% | -35.82% | -22.82% | -49.58% | -35.01% | -24.92% | |||||
| EPS Growth (1Y) | 62.29% | -12.70% | -35.12% | -63.15% | -78.01% | -76.41% | -86.12% | -81.24% | -73.78% | -63.18% | -47.79% | -28.96% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -2.82 | -5.42 | -11.31 | -8.48 | -5.00 | -1.31 | -1.65 | -1.09 | -1.36 | -0.61 | -0.35 | -1.37 | |||||
| P/B TTM | 2.29 | 3.22 | 5.86 | 4.08 | 2.94 | 9.51 | 5.16 | 5.69 | 8.75 | 4.01 | 0.47 | -45.36 | |||||
| P/S TTM | 776.77 | 1,347.81 | 77.26 | 76.09 | 25.36 | 13.52 | 21.25 | 345.49 | -148.88 | 32.99 | 4.03 | 16.04 | |||||
| Market Cap | 24.69M | 42.83M | 70.70M | 38.69M | 15.87M | 6.89M | 8.47M | 8.76M | 12.75M | 5.03M | 4.22M | 17.21M | |||||
| Enterprise Value | 24.63M | 42.26M | 70.66M | 38.73M | 15.91M | 6.86M | 8.60M | 9.82M | 13.80M | 5.78M | 5.60M | 19.76M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -3.34M | -2.99M | -3.10M | -2.08M | -1.39M | -1.81M | -1.54M | -2.98M | -3.67M | -4.21M | -4.24M | -3.38M | |||||
| Net Debt | -51.59K | -571.47K | -44.81K | 49.82K | 41.84K | -23.56K | 126.38K | 1.06M | 1.04M | 751.93K | 1.39M | 2.56M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2010-05-11Purchase
Owner: Nirta, Joseph
Title: -
Shares: 10,000
Price/Share: $0.15
Value: $1,500.00
Shares Owned: 10,000
Relationship: Director
Ownership: Indirect
2009-11-13Purchase
Owner: Smith, J.B.
Title: -
Shares: 714,286
Price/Share: $50000.00
Value: $35,714,300,000.00
Shares Owned: 16,585,538
Relationship: Director,TenPercentOwner
Ownership: Indirect
2009-08-31Purchase
Owner: Smith, J.B.
Title: -
Shares: 192,308
Price/Share: $50000.00
Value: $9,615,400,000.00
Shares Owned: 18,430,752
Relationship: Director,TenPercentOwner
Ownership: Indirect
2009-06-10Purchase
Owner: Smith, J.B.
Title: -
Shares: 20
Price/Share: $20000.00
Value: $400,000.00
Shares Owned: 336
Relationship: Director,TenPercentOwner
Ownership: Indirect
2009-06-02Purchase
Owner: Smith, J.B.
Title: -
Shares: 95
Price/Share: $47500.00
Value: $4,512,500.00
Shares Owned: 2,436
Relationship: Director,TenPercentOwner
Ownership: Indirect
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
3.21%
Inst. Shares: 816,526
Shares Outstanding: 25,448,516
2025-12-31
4.26%
Inst. Shares: 856,228
Shares Outstanding: 20,108,944
2025-09-30
3.37%
Inst. Shares: 784,223
Shares Outstanding: 23,256,590
2025-06-30
4.23%
Inst. Shares: 734,754
Shares Outstanding: 17,386,536
2025-03-31
3.84%
Inst. Shares: 574,994
Shares Outstanding: 14,968,232
ABVC BIOPHARMA, INC. (ABVC) — SEC Financial Statements & Analysis
ABVC BIOPHARMA, INC. (ABVC) is a pharmaceutical preparations company, incorporated in NV. ABVC BIOPHARMA, INC. trades on Nasdaq as: ABVC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ABVC BIOPHARMA, INC. reported a -94.92% year-over-year revenue growth, a Gross Profit Margin of 99.85% (TTM), a Debt-to-Equity ratio of 0.64x, a Price-to-Sales (P/S) ratio of 776.77x (TTM), a Price-to-Book (P/B) ratio of 2.29 (TTM), at a market cap of $24.69M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -94.92%
- Gross Profit Margin TTM
- 99.85%
- Debt To Equity
- 0.64x
- P/S TTM
- 776.77x
- P/B TTM
- 2.29
- Market Cap
- $24.69M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ABVC BIOPHARMA, INC. in?
ABVC BIOPHARMA, INC. (ABVC) operates in the Pharmaceutical Preparations industry.
What is ABVC's market cap?
ABVC BIOPHARMA, INC. (ABVC) has a market capitalization of $24.69M as of 2026-03-31.
What exchange does ABVC trade on?
ABVC BIOPHARMA, INC. (ABVC) trades on the Nasdaq.
Where is ABVC BIOPHARMA, INC. incorporated?
ABVC BIOPHARMA, INC. is incorporated in NV.